Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 16740697)

1.

Regression of latent endometrial precancers by progestin infiltrated intrauterine device.

Ørbo A, Rise CE, Mutter GL.

Cancer Res. 2006 Jun 1;66(11):5613-7.

2.

Involution of latent endometrial precancers by hormonal and nonhormonal mechanisms.

Lin MC, Burkholder KA, Viswanathan AN, Neuberg D, Mutter GL.

Cancer. 2009 May 15;115(10):2111-8. doi: 10.1002/cncr.24218.

3.
4.

Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer.

Monte NM, Webster KA, Neuberg D, Dressler GR, Mutter GL.

Cancer Res. 2010 Aug 1;70(15):6225-32. doi: 10.1158/0008-5472.CAN-10-0149. Epub 2010 Jul 14.

5.

Emergence, involution, and progression to carcinoma of mutant clones in normal endometrial tissues.

Mutter GL, Monte NM, Neuberg D, Ferenczy A, Eng C.

Cancer Res. 2014 May 15;74(10):2796-802. doi: 10.1158/0008-5472.CAN-14-0108. Epub 2014 Mar 24. Erratum in: Cancer Res. 2014 Jul 1;74(13):3644.

6.

Involution of PTEN-null endometrial glands with progestin therapy.

Zheng W, Baker HE, Mutter GL.

Gynecol Oncol. 2004 Mar;92(3):1008-13.

PMID:
14984979
7.

Molecular identification of latent precancers in histologically normal endometrium.

Mutter GL, Ince TA, Baak JP, Kust GA, Zhou XP, Eng C.

Cancer Res. 2001 Jun 1;61(11):4311-4.

8.

Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers.

Mutter GL, Lin MC, Fitzgerald JT, Kum JB, Baak JP, Lees JA, Weng LP, Eng C.

J Natl Cancer Inst. 2000 Jun 7;92(11):924-30.

9.

Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia--precursor of endometrial cancer.

Wang S, Pudney J, Song J, Mor G, Schwartz PE, Zheng W.

Gynecol Oncol. 2003 Feb;88(2):108-17.

PMID:
12586588
10.

The effects of progesterone and progestins on endometrial proliferation.

Moyer DL, Felix JC.

Contraception. 1998 Jun;57(6):399-403.

PMID:
9693400
11.

Precancerous lesions of the endometrium and medical treatment.

Taddei GL, Bargelli G, Scarselli B, Moncini D, Scarselli G.

Eur J Contracept Reprod Health Care. 1997 Dec;2(4):239-41. Review.

PMID:
9678079
12.

Utility of PTEN expression of endometrial "surface epithelial changes" and underlying atypical endometrial hyperplasia.

Quddus MR, Ologun BA, Sung CJ, Steinhoff MM, Lawrence WD.

Int J Gynecol Pathol. 2009 Sep;28(5):471-6. doi: 10.1097/PGP.0b013e3181a06f96.

PMID:
19696618
13.

Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.

Raudaskoski TH, Lahti EI, Kauppila AJ, Apaja-Sarkkinen MA, Laatikainen TJ.

Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):114-9.

PMID:
7847516
14.

Fertility-sparing treatment of endometrial cancer precursors among young women: a reproductive point of view.

Ricciardi E, Maniglio P, Frega A, Marci R, Caserta D, Moscarini M.

Eur Rev Med Pharmacol Sci. 2012 Dec;16(14):1934-7.

15.
16.

Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.

Suvanto-Luukkonen E, Malinen H, Sundström H, Penttinen J, Kauppila A.

Acta Obstet Gynecol Scand. 1998 Aug;77(7):758-63.

PMID:
9740525
17.

Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy.

Penner KR, Dorigo O, Aoyama C, Ostrzega N, Balzer BL, Rao J, Walsh CS, Cass I, Holschneider CH.

Gynecol Oncol. 2012 Mar;124(3):542-8. doi: 10.1016/j.ygyno.2011.11.004. Epub 2011 Nov 10.

PMID:
22079678
18.

Comparison of dilatation & curettage and endometrial aspiration biopsy accuracy in patients treated with high-dose oral progestin plus levonorgestrel intrauterine system for early-stage endometrial cancer.

Kim MK, Seong SJ, Song T, Kim ML, Yoon BS, Jun HS, Lee GH, Lee YH.

Gynecol Oncol. 2013 Sep;130(3):470-3. doi: 10.1016/j.ygyno.2013.06.035. Epub 2013 Jun 30.

PMID:
23822890
19.

Combined phospho-Akt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of the endometrium.

Minaguchi T, Nakagawa S, Takazawa Y, Nei T, Horie K, Fujiwara T, Osuga Y, Yasugi T, Kugu K, Yano T, Yoshikawa H, Taketani Y.

Cancer Lett. 2007 Apr 8;248(1):112-22. Epub 2006 Aug 21.

PMID:
16919866
20.

Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.

Wheeler DT, Bristow RE, Kurman RJ.

Am J Surg Pathol. 2007 Jul;31(7):988-98.

PMID:
17592264
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk